All Stories

  1. Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

    Article • Expert Opinion on Orphan Drugs, August 2019, Taylor & Francis

    Manuel Posada

  2. Temporal and Cartographic Analyses of the Distribution within Spain of Mortality Due to Granulomatosis with Polyangiitis (1984–2016)

    Article • International Journal of Environmental Research and Public Health, April 2019, MDPI AG

    Manuel Posada

  3. Schooling of Children with Rare Diseases and Disability in Europe

    Article • International Journal of Disability Development and Education, January 2019, Taylor & Francis

    Prof Márta Péntek, Manuel Posada

  4. Mortality Due to Cystic Fibrosis over a 36-Year Period in Spain: Time Trends and Geographic Variations

    Article • International Journal of Environmental Research and Public Health, January 2019, MDPI AG

    Manuel Posada

  5. Geographic Analysis of Motor Neuron Disease Mortality and Heavy Metals Released to Rivers in Spain

    Article • International Journal of Environmental Research and Public Health, November 2018, MDPI AG

    Manuel Posada

  6. SpainUDP: The Spanish Undiagnosed Rare Diseases Program

    Article • International Journal of Environmental Research and Public Health, August 2018, MDPI AG

    Manuel Posada

  7. A Nationwide Registry-Based Study on Mortality Due to Rare Congenital Anomalies

    Article • International Journal of Environmental Research and Public Health, August 2018, MDPI AG

    Manuel Posada

  8. Recommendations for Improving the Quality of Rare Disease Registries

    Article • International Journal of Environmental Research and Public Health, August 2018, MDPI AG

    Manuel Posada

  9. SpainUDP: The Spanish Undiagnosed Rare Diseases Program

    Article • June 2018, MDPI AG

    Manuel Posada

  10. Measurement Issues: Building a theoretical framework for autism spectrum disorders screening instruments in Europe

    Article • Child and Adolescent Mental Health, December 2017, Wiley

    Tony Charman, Manuel Posada

  11. Early Detection and Intervention of ASD: A European Overview

    Article • Brain Sciences, December 2017, MDPI AG

    Manuel Posada

  12. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database

    Article • Journal of Neuromuscular Diseases, November 2017, IOS Press

    Manuel Posada

  13. Congenital Anomalies: Cluster Detection and Investigation

    Article • January 2017, Springer Science + Business Media

    EVA BERMEJO-SANCHEZ, Manuel Posada

  14. Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web Layer

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    José Luis Oliveira, Manuel Posada

  15. Data Quality in Rare Diseases Registries

    Article • January 2017, Springer Science + Business Media

    Manuel Posada

  16. Improved Diagnosis and Care for Rare Diseases through Implementation of Precision Public Health Framework

    Article • January 2017, Springer Science + Business Media

    Manuel Posada

  17. Mortality Statistics and their Contribution to Improving the Knowledge of Rare Diseases Epidemiology: The Example of Hereditary Ataxia in Europe

    Article • January 2017, Springer Science + Business Media

    Manuel Posada

  18. Preparing for the Future of Rare Diseases

    Article • January 2017, Springer Science + Business Media

    Manuel Posada

  19. Rare Disease Biospecimens and Patient Registries: Interoperability for Research Promotion, a European Example: EuroBioBank and SpainRDR-BioNER

    Article • January 2017, Springer Science + Business Media

    Manuel Posada

  20. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data

    Article • January 2017, Springer Science + Business Media

    Manuel Posada

  21. Operationalisation of the European Protocol for Autism Prevalence (EPAP) for Autism Spectrum Disorder Prevalence Measurement in Ireland

    Article • Journal of Autism and Developmental Disorders, June 2016, Springer Science + Business Media

    Manuel Posada

  22. Characterization of immune cell phenotypes in adults with autism spectrum disorders

    Article • Journal of Investigative Medicine, June 2016, BMJ

    Manuel Posada

  23. The risk of re-identification versus the need to identify individuals in rare disease research

    Article • European Journal of Human Genetics, May 2016, Springer Science + Business Media

    Manuel Posada

  24. Bortezomib for the treatment of acute lymphoblastic leukemia

    Article • Expert Opinion on Orphan Drugs, May 2016, Taylor & Francis

    Manuel Posada

  25. Patient participation in the development of a clinical guideline for inherited retinal dystrophies

    Article • Expert Opinion on Orphan Drugs, May 2016, Taylor & Francis

    Mrs Rosa M Coco Martin, Manuel Posada

  26. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Manuel Posada

  27. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Manuel Posada

  28. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Manuel Posada

  29. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Manuel Posada

  30. Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Manuel Posada

  31. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Manuel Posada

  32. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Manuel Posada

  33. Social/economic costs and health-related quality of life in patients with scleroderma in Europe

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Manuel Posada

  34. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Manuel Posada

  35. Social/economic costs and quality of life in patients with haemophilia in Europe

    Article • The European Journal of Health Economics, April 2016, Springer Science + Business Media

    Manuel Posada

  36. Modified checklist for autism in toddlers cross-cultural adaptation for Argentina

    Article • International Journal of Developmental Disabilities, February 2016, Taylor & Francis

    Manuel Posada

  37. Improving the informed consent process in international collaborative rare disease research: effective consent for effective research

    Article • European Journal of Human Genetics, February 2016, Springer Science + Business Media

    Manuel Posada

  38. Monitoring Huntington's Disease Mortality across a 30-Year Period: Geographic and Temporal Patterns

    Article • Neuroepidemiology, January 2016, Karger Publishers

    EVA BERMEJO-SANCHEZ, Manuel Posada

  39. Impact of rare diseases in oral health

    Article • Medicina Oral Patología Oral y Cirugia Bucal, January 2016, Medicina Oral, S.L.

    Manuel Posada

  40. The Quality of Rare Disease Registries: Evaluation and Characterization

    Article • Public Health Genomics, January 2016, Karger Publishers

    Manuel Posada

  41. Fragile X syndrome: economic burden and health-related quality of life of patients and caregivers in France

    Article • Journal of Intellectual Disability Research, September 2015, Wiley

    Manuel Posada

  42. Consensus on the criteria needed for creating a rare-disease patient registry. A Delphi study

    Article • Journal of Public Health, August 2015, Oxford University Press (OUP)

    Manuel Posada

  43. Fish consumption patterns and hair mercury levels in children and their mothers in 17 EU countries

    Article • Environmental Research, August 2015, Elsevier

    Prof ADAMOS HADJIPANAYIS, Manuel Posada

  44. A pilot study on the feasibility of European harmonized human biomonitoring: Strategies towards a common approach, challenges and opportunities

    Article • Environmental Research, August 2015, Elsevier

    Prof ADAMOS HADJIPANAYIS, Manuel Posada

  45. Recruitment procedures for descriptive socio-economic studies in rare diseases. The BURQOL-RD project

    Article • Expert Opinion on Orphan Drugs, June 2015, Informa Healthcare

    Manuel Posada

  46. La detección e intervención tempranas en menores con trastorno del espectro autista

    Article • Siglo Cero, April 2015, Ediciones Universidad de Salamanca

    Manuel Posada

  47. The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations

    Article • Human Mutation, March 2015, Wiley

    Manuel Posada

  48. Current trends in biobanking for rare diseases: a review [Corrigendum]

    Article • Journal of Biorepository Science for Applied Medicine, March 2015, Taylor & Francis

    Franz Schaefer, Manuel Posada

  49. Identifying data sources for a national population-based registry: the experience of the Spanish Rare Diseases Registry

    Article • Public Health, March 2015, Elsevier

    Manuel Posada

  50. The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases

    Article • European Journal of Human Genetics, December 2014, Springer Science + Business Media

    Prof Corrado Angelini, Manuel Posada

  51. The economic burden and health-related quality of life associated with systemic sclerosis in France

    Article • Scandinavian Journal of Rheumatology, December 2014, Taylor & Francis

    Manuel Posada

  52. Current trends in biobanking for rare diseases: a review

    Article • Journal of Biorepository Science for Applied Medicine, November 2014, Taylor & Francis

    Franz Schaefer, Manuel Posada

  53. The EPIRARE proposal of a set of indicators and common data elements for the European platform for rare disease registration

    Article • Archives of Public Health, October 2014, Springer Science + Business Media

    Manuel Posada

  54. Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid

    Article • October 2014, Springer Science + Business Media

    Manuel Posada

  55. National Registries of Rare Diseases in Europe: An Overview of the Current Situation and Experiences

    Article • Public Health Genomics, September 2014, Karger Publishers

    Manuel Posada

  56. Registros de enfermedades respiratorias integrados en el Registro Nacional de Enfermedades Raras

    Article • Archivos de Bronconeumología (English Edition), September 2014, Elsevier

    Manuel Posada

  57. Respiratory Diseases Registries in the National Registry of Rare Diseases

    Article • Archivos de Bronconeumología (English Edition), September 2014, Elsevier

    Manuel Posada

  58. RD-Connect: An Integrated Platform Connecting Databases, Registries, Biobanks and Clinical Bioinformatics for Rare Disease Research

    Article • Journal of General Internal Medicine, July 2014, Springer Science + Business Media

    Manuel Posada

  59. Screening for autism spectrum disorders: state of the art in Europe

    Article • European Child & Adolescent Psychiatry, June 2014, Springer Science + Business Media

    Tony Charman, Manuel Posada

  60. Programa de detección precoz de trastornos generalizados del desarrollo en las áreas de salud de Salamanca y Zamora

    Article • Anales de Pediatría, May 2014, Elsevier

    Manuel Posada

  61. Social Economic Costs and Health-Related Quality of Life in Patients With Systemic Sclerosis in Spain

    Article • Arthritis Care & Research, February 2014, Wiley

    Manuel Posada

  62. Association of Immunological Cell Profiles with Specific Clinical Phenotypes of Scleroderma Disease

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Manuel Posada

  63. National Rare Disease Registries: overview from Spain

    Article • Orphanet Journal of Rare Diseases, January 2014, Springer Science + Business Media

    Manuel Posada

  64. National rare diseases registry in Spain: pilot study of the Spanish Rare Diseases Registries Research Network (SpainRDR)

    Article • Orphanet Journal of Rare Diseases, January 2014, Springer Science + Business Media

    Manuel Posada

  65. RARE-Bestpractices: a platform for sharing best practices for the management of rare diseases

    Article • Orphanet Journal of Rare Diseases, January 2014, Springer Science + Business Media

    Manuel Posada

  66. Trends in systemic lupus erythematosus mortality in Spain from 1981 to 2010

    Article • Lupus, December 2013, SAGE Publications

    Manuel Posada

  67. The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia

    Article • Human Mutation, August 2013, Wiley

    Manuel Posada

  68. Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries

    Article • The European Journal of Health Economics, July 2013, Springer Science + Business Media

    Manuel Posada

  69. ¿Hay lugar en atención primaria para las enfermedades poco frecuentes? El caso de la fibrodisplasia osificante progresiva

    Article • Atención Primaria, June 2013, Elsevier

    Manuel Posada

  70. Mortality of congenital osteochondrodysplasias: A nationwide registry‐based study

    Article • American Journal of Medical Genetics Part A, May 2013, Wiley

    Manuel Posada

  71. Análisis de costes y carga de enfermedad

    Article • Revista Clínica Española, April 2013, Elsevier

    Manuel Posada

  72. EUROPLAN: A Project to Support the Development of National Plans on Rare Diseases in Europe

    Article • Public Health Genomics, January 2013, Karger Publishers

    Manuel Posada

  73. Epidemiology of Hereditary Ataxias in Spain: Hospital Discharge Registry and Population-Based Mortality Study

    Article • Neuroepidemiology, January 2013, Karger Publishers

    Manuel Posada

  74. The Current Situation and Needs of Rare Disease Registries in Europe

    Article • Public Health Genomics, January 2013, Karger Publishers

    Manuel Posada

  75. Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study

    Article • Health Policy, November 2012, Elsevier

    Manuel Posada

  76. Further evidence supporting a genetic background for Paget's disease of bone in Spain

    Article • Anthropologischer Anzeiger, November 2012, Schweizerbart

    Manuel Posada

  77. Fibrodysplasia ossificans progressiva in Spain: epidemiological, clinical, and genetic aspects

    Article • Bone, October 2012, Elsevier

    Manuel Posada

  78. The need for worldwide policy and action plans for rare diseases

    Article • Acta Paediatrica, May 2012, Wiley

    Manuel Posada

  79. Cost-effectiveness analysis of burning mouth syndrome therapy

    Article • Community Dentistry And Oral Epidemiology, November 2011, Wiley

    Manuel Posada

  80. Proteomics of toxic oil syndrome in humans: Phenotype distribution in a population of patients

    Article • Chemico-Biological Interactions, June 2011, Elsevier

    Manuel Posada

  81. Clasificación de las enfermedades constitucionales del hueso: lo que va de ayer a hoy

    Article • Reumatología Clínica, March 2011, Elsevier

    Manuel Posada

  82. Increase in motor neuron disease mortality in Spain: Temporal and geographical analysis (1990–2005)

    Article • Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, January 2011, Taylor & Francis

    Manuel Posada

  83. Classification of constitutional disorders of bone: a new perspective

    Article • Reumatología Clínica (English Edition), January 2011, Elsevier

    Manuel Posada

  84. Modified Checklist for Autism in Toddlers: Cross-Cultural Adaptation and Validation in Spain

    Article • Journal of Autism and Developmental Disorders, December 2010, Springer Science + Business Media

    Manuel Posada

  85. Concepto, epidemiología, situación actual y perspectivas futuras

    Article • Atención Primaria, March 2010, Elsevier

    Manuel Posada

  86. Rare Diseases Epidemiology Research

    Article • January 2010, Springer Science + Business Media

    Manuel Posada

  87. Rare Diseases – Avoiding Misperceptions and Establishing Realities: The Need for Reliable Epidemiological Data

    Article • January 2010, Springer Science + Business Media

    Manuel Posada

  88. Rare Diseases Epidemiology

    Article • January 2010, Springer Science + Business Media

    Manuel Posada

  89. Patient involvement in health research: A contribution to a systematic review on the effectiveness of treatments for degenerative ataxias

    Article • Social Science & Medicine, September 2009, Elsevier

    Manuel Posada

  90. Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model

    Article • Pharmacoepidemiology and Drug Safety, November 2008, Wiley

    Manuel Posada

  91. Enfermedades raras: datos impropios para un problema grave

    Article • Medicina Clínica, July 2008, Elsevier

    Manuel Posada

  92. Cystic fibrosis mortality trends in Spain among infants and young children: 1981–2004

    Article • European Journal of Epidemiology, June 2008, Springer Science + Business Media

    Manuel Posada

  93. High prevalence of cardiovascular risk in patients with toxic oil syndrome: A comparative study using the general Spanish population

    Article • European Journal of Internal Medicine, January 2008, Elsevier

    Manuel Posada

  94. Estimating the Burden of Disease for Autism Spectrum Disorders in Spain in 2003

    Article • Journal of Autism and Developmental Disorders, June 2007, Springer Science + Business Media

    Manuel Posada

  95. Enfermedades raras

    Article • FMC - Formación Médica Continuada en Atención Primaria, May 2007, Elsevier

    Manuel Posada

  96. Evolución secular y por comunidades autónomas de la frecuencia de síndrome de Down al nacimiento en hijos de madres jóvenes

    Article • Progresos de Obstetricia y Ginecología, February 2007, Sociedad Espanola de Nutricion Parenteral y Enteral (SENPE)

    EVA BERMEJO-SANCHEZ, Manuel Posada

  97. Child health and the environment: the INMA Spanish Study

    Article • Paediatric and Perinatal Epidemiology, September 2006, Wiley

    Manuel Posada

  98. Estrés relacionado con el trabajo y exposición laboral en enfermeras de la Comunidad de Castilla y León

    Article • Enfermería Clínica, May 2006, Elsevier

    Manuel Posada

  99. Respuesta de los autores

    Article • Medicina Clínica, April 2006, Elsevier

    Manuel Posada

  100. Genetic approaches in the understanding of Toxic Oil Syndrome

    Article • Toxicology Letters, February 2006, Elsevier

    Manuel Posada

  101. Toxic oil syndrome: Genetic restriction and immunomodulatory effects due to adulterated oils in a model of HLA transgenic mice

    Article • Toxicology Letters, November 2005, Elsevier

    Manuel Posada

  102. Análisis de la producción científica española sobre enfermedades raras: 1990-2000

    Article • Medicina Clínica, September 2005, Elsevier

    Manuel Posada

  103. Quality of life, disability and handicap in patients with toxic oil syndrome

    Article • Journal of Advanced Nursing, June 2005, Wiley

    Manuel Posada

  104. Determination of protein markers in human serum: Analysis of protein expression in toxic oil syndrome studies

    Article • PROTEOMICS, February 2004, Wiley

    Manuel Posada

  105. Rendimiento diagnóstico de la indicación de ecocardiografía en el seguimiento de los pacientes con «síndrome del aceite tóxico»

    Article • Revista Española de Cardiología, December 2003, Elsevier

    Manuel Posada

  106. Prevalencia de factores de riesgo cardiovascular en una cohorte de afectados por el síndrome del aceite tóxico

    Article • Medicina Clínica, October 2003, Elsevier

    Manuel Posada

  107. Toxic oil syndrome: Survival in the whole cohort between 1981 and 1995

    Article • Journal of Clinical Epidemiology, July 2003, Elsevier

    Manuel Posada

  108. Characteristics of disability and handicap among toxic oil syndrome (TOS) cohort patients: a cross-sectional study, 17 years after the original food intoxication

    Article • Disability and Rehabilitation, January 2003, Taylor & Francis

    Manuel Posada

  109. Carpal tunnel syndrome. A new feature in the natural history of TOS?

    Article • European Journal of Epidemiology, October 2002, Springer Science + Business Media

    Manuel Posada

  110. Immunoglobulin and autoantibody responses in MRL/lpr mice treated with ‘toxic oils’

    Article • Toxicology, September 2002, Elsevier

    Manuel Posada

  111. On-Line HPLC-UV-mass spectrometry and tandem mass spectrometry for the rapid delineation and characterization of differences in complex mixtures: a case study using toxic oil variants

    Article • Biomedical Chromatography, January 2002, Wiley

    Manuel Posada

  112. ¿Cómo enfrentarse a una crisis en Salud Pública?

    Article • Medifam, January 2002, Instituto de Salud Carlos III/BNCS/SciELO Espana

    Manuel Posada

  113. Síndrome del aceite tóxico y paracetamol

    Article • Atención Primaria, January 2002, Elsevier

    Manuel Posada

  114. Automated Strong Cation Exchange Extraction of Fatty Acid Esters of 3-(N-Phenylamino)-1,2-propanediol from Oil Samples for Routine Quantification by HPLC-APCI/MS/MS

    Article • Journal of Agricultural and Food Chemistry, November 2001, American Chemical Society (ACS)

    Manuel Posada

  115. Pathology of “Toxic Oils” and Selected Metals in the MRL/lpr Mouse

    Article • Toxicologic Pathology, October 2001, SAGE Publications

    Manuel Posada

  116. Determination of Aniline Derivatives in Oils Related to the Toxic Oil Syndrome by Atmospheric Pressure Ionization-Tandem Mass Spectrometry

    Article • Analytical Chemistry, August 2001, American Chemical Society (ACS)

    Manuel Posada

  117. Storage time and deodorization temperature influence the formation of aniline-derived compounds in denatured rapeseed oils

    Article • Food and Chemical Toxicology, January 2001, Elsevier

    Manuel Posada

  118. Bioterrorismo y salud pública

    Article • Gaceta Sanitaria, January 2001, Elsevier

    Manuel Posada

  119. DR2 antigens are associated with severity of disease in toxic oil syndrome (TOS)

    Article • Tissue Antigens, February 2000, Wiley

    Manuel Posada

  120. Late Deaths among Young Women Affected by the Toxic Oil Syndrome in Spain

    Article • Epidemiology, May 1999, Wolters Kluwer Health

    Manuel Posada

  121. Umbilical cord blood banking for unrelated transplantation

    Article • Experimental Hematology, February 1999, Elsevier

    Manuel Posada

  122. Pentachlorophenol and Pentachloroanisole in Oil Samples Associated with the Toxic Oil Syndrome

    Article • Bulletin of Environmental Contamination and Toxicology, January 1999, Springer Science + Business Media

    Manuel Posada

  123. Toxic oil syndrome mortality: the first 13 years

    Article • International Journal of Epidemiology, December 1998, Oxford University Press (OUP)

    Manuel Posada

  124. Health Status Measurement in Toxic Oil Syndrome

    Article • Journal of Clinical Epidemiology, October 1998, Elsevier

    Manuel Posada

  125. Rapid HPLC screening method for contaminants found in implicatedL-tryptophan associated with eosinophilia myalgia syndrome and adulterated rapeseed oil associated with toxic oil syndrome

    Article • Biomedical Chromatography, September 1998, Wiley

    Manuel Posada

  126. Cytokine mRNA expression in lung tissue from toxic oil syndrome patients: a TH2 immunological mechanism

    Article • Toxicology, March 1997, Elsevier

    Manuel Posada

  127. Toxicologists versus Toxicological Disasters: Toxic Oil Syndrome, Clinical Aspects

    Article • January 1997, Springer Science + Business Media

    Manuel Posada

  128. Toxicologists versus toxicological disasters: Toxic oil syndrome (TOS). Analytical chemistry/analytical toxicology

    Article • Toxicology Letters, October 1996, Elsevier

    Manuel Posada

  129. Toxic oil syndrome: Traceback of the toxic, oil and evidence for a point source epidemic

    Article • Food and Chemical Toxicology, March 1996, Elsevier

    Manuel Posada

  130. Products of Aniline and Triglycerides in Oil Samples Associated with the Toxic Oil Syndrome

    Article • Chemical Research in Toxicology, January 1996, American Chemical Society (ACS)

    Manuel Posada

  131. Immunological basis of toxic oil syndrome (TOS)

    Article • Toxicology, November 1994, Elsevier

    Manuel Posada

  132. Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8–10, 1991, World Health Organization Meeting report

    Article • Seminars in Arthritis and Rheumatism, October 1993, Elsevier

    Manuel Posada

  133. Mortality among People Affected by Toxic Oil Syndrome

    Article • International Journal of Epidemiology, January 1993, Oxford University Press (OUP)

    Manuel Posada

  134. Cardiac abnormalities in the toxic oil syndrome, with comparative observations on the eosinophilia-myalgia syndrome

    Article • Journal of the American College of Cardiology, November 1991, Elsevier

    Manuel Posada

  135. Toxic oil syndrome: A current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome

    Article • Journal of the American College of Cardiology, September 1991, Elsevier

    Manuel Posada

  136. Histologic abnormalities of large and small coronary arteries, neural structures, and the conduction system of the heart found in postmortem studies of individuals dying from the toxic oil syndrome

    Article • American Heart Journal, March 1991, Elsevier

    Manuel Posada

  137. Manufacturing processes at two French rapeseed oil companies: Possible relationships to toxic oil syndrome in Spain

    Article • Food and Chemical Toxicology, January 1991, Elsevier

    Manuel Posada

  138. Late cases of toxic oil syndrome: Evidence that the aetiological agent persisted in oil stored for up to one year

    Article • Food and Chemical Toxicology, January 1989, Elsevier

    Manuel Posada

  139. Synthesis of N-(5-vinyl-1,3-thiazolidin-2-ylidene)phenylamine and analysis of oils implicated in the spanish toxic oil syndrome for its presence

    Article • Food and Chemical Toxicology, January 1989, Elsevier

    Manuel Posada

  140. Toxic-oil syndrome: Case reports associated with the ITH oil refinery in Sevilla

    Article • Food and Chemical Toxicology, January 1987, Elsevier

    Manuel Posada

  141. Esophagus and toxic oil syndrome

    Article • Digestive Diseases and Sciences, April 1986, Springer Science + Business Media

    Manuel Posada

  142. SPANISH TOXIC OIL AND CONGENITAL MALFORMATIONS

    Article • The Lancet, January 1983, Elsevier

    Manuel Posada